Stem cell not big , you are talking to the wrong vet , Ho hum, have a look at MSB a Melbourne company, TEVA is paying a few billion in there phase 3 trials.. they have 4 phase 3 in situ worth many Billions and this vet says ho hum , douBt me not USA will not be the main game MSB aust. will be the main game....Back to MLA will hold 100% of Medivet US in the coming months, it was to comlacted to take the 100 % in the first intance but its coming , Cheers VIN
MLA Price at posting:
18.0¢ Sentiment: LT Buy Disclosure: Held
